Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma. (British Journal of Haematology, 2017)

(untitled) - Eyre, T; Osborne, W; Gallop-Evans, E; Ardeshna, K; Kassam, S; Sadullah, S; Sidra, G; Culligan, D; Arumainathan, A; Shankara, P; Bowles, K; Eyre, D; et al.